• 1. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

Introduction to Methyl 4-bromo-2,3-dimethylbenzoate (CAS No. 6021-32-5)

Methyl 4-bromo-2,3-dimethylbenzoate, identified by its Chemical Abstracts Service (CAS) number 6021-32-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound belongs to the class of aromatic esters, characterized by its ester functional group attached to a benzene ring that is further substituted with bromine and two methyl groups at the 2 and 3 positions, respectively. The unique structural configuration of methyl 4-bromo-2,3-dimethylbenzoate makes it a valuable intermediate in synthetic chemistry and a potential candidate for various applications in medicinal chemistry.

The synthesis of methyl 4-bromo-2,3-dimethylbenzoate typically involves the bromination of 2,3-dimethylbenzoic acid followed by esterification. This process highlights the compound's utility as a building block in organic synthesis. The presence of the bromine atom at the para position relative to the ester group enhances its reactivity, making it a versatile precursor for further functionalization. In recent years, the interest in such brominated aromatic esters has surged due to their role in developing novel pharmaceuticals and agrochemicals.

In the context of pharmaceutical research, methyl 4-bromo-2,3-dimethylbenzoate has garnered attention for its potential applications in drug discovery. The bromine substituent allows for further modifications via cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures. These reactions enable the introduction of diverse functional groups, facilitating the development of new therapeutic agents. For instance, researchers have explored its use in synthesizing small-molecule inhibitors targeting various biological pathways.

One of the most compelling aspects of methyl 4-bromo-2,3-dimethylbenzoate is its role in designing molecules with enhanced binding affinity to biological targets. The dimethyl substitution at the ortho positions influences the electronic properties of the benzene ring, thereby modulating interactions with proteins and enzymes. This feature has been exploited in the development of kinase inhibitors and other targeted therapies. Recent studies have demonstrated its utility in creating compounds that exhibit potent activity against diseases such as cancer and inflammatory disorders.

The compound's structural features also make it an attractive candidate for material science applications. For example, its ability to participate in π-stacking interactions with other aromatic compounds suggests potential uses in organic electronics and liquid crystal displays (LCDs). Additionally, the bromine atom can be selectively removed or replaced under controlled conditions, allowing for fine-tuning of material properties. Such flexibility has been leveraged in designing novel polymers and coatings with specific functionalities.

Emerging research indicates that methyl 4-bromo-2,3-dimethylbenzoate may play a role in sustainable chemistry initiatives. The efficient synthesis and functionalization of this compound offer opportunities for greener chemical processes. For instance, catalytic methods have been developed to minimize waste and improve yields during its preparation. These advancements align with global efforts to promote environmentally friendly chemical practices.

The pharmacological potential of methyl 4-bromo-2,3-dimethylbenzoate extends beyond traditional drug development. It has been investigated as a precursor for bioactive molecules with antimicrobial properties. The structural motifs present in this compound can be incorporated into derivatives that exhibit potent activity against resistant bacterial strains. Such findings are particularly relevant given the growing concern over antibiotic resistance worldwide.

In conclusion, methyl 4-bromo-2,3-dimethylbenzoate (CAS No. 6021-32-5) is a multifaceted compound with significant implications in pharmaceuticals, materials science, and sustainable chemistry. Its unique structural features and reactivity make it a valuable tool for synthetic chemists and researchers seeking to develop innovative solutions to complex challenges. As scientific understanding progresses, it is likely that new applications for this compound will continue to emerge, further solidifying its importance in modern chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)